Sargent Investment Group LLC Lowers Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Sargent Investment Group LLC decreased its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,205 shares of the company’s stock after selling 205 shares during the quarter. Sargent Investment Group LLC’s holdings in Henry Schein were worth $318,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of HSIC. McGlone Suttner Wealth Management Inc. purchased a new position in Henry Schein during the fourth quarter worth approximately $39,000. Baystate Wealth Management LLC boosted its position in Henry Schein by 2,500.0% during the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock worth $39,000 after purchasing an additional 500 shares in the last quarter. Neo Ivy Capital Management purchased a new position in Henry Schein during the third quarter worth approximately $46,000. Covestor Ltd boosted its position in Henry Schein by 22.8% during the third quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after purchasing an additional 254 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new position in Henry Schein during the fourth quarter worth approximately $115,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on HSIC. SVB Leerink began coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price target on the stock. Evercore ISI increased their price target on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Piper Sandler raised their target price on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research report on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Henry Schein currently has an average rating of “Hold” and an average target price of $81.09.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Price Performance

NASDAQ:HSIC opened at $73.13 on Monday. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The stock has a market cap of $9.40 billion, a PE ratio of 23.22, a P/E/G ratio of 1.81 and a beta of 0.87. The stock has a 50 day moving average price of $74.17 and a 200 day moving average price of $72.41.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.70 by ($0.04). The business had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. Henry Schein’s revenue was down 10.5% compared to the same quarter last year. During the same period last year, the business earned $1.21 EPS. Equities research analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.